- Previous Close
0.0285 - Open
0.0255 - Bid --
- Ask --
- Day's Range
0.0255 - 0.0255 - 52 Week Range
0.0095 - 0.0660 - Volume
20 - Avg. Volume
0 - Market Cap (intraday)
6.516M - Beta (5Y Monthly) 0.47
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Britannia Life Sciences Inc. engages in the provision of product testing, safety assessment, and compliance services primarily to the cosmetics, consumer packaged and household goods, and nutraceutical industries in the United Kingdom and internationally. The company is headquartered in Toronto, Canada.
britannia.lifeRecent News: L020.F
View MorePerformance Overview: L020.F
Trailing total returns as of 10/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: L020.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: L020.F
View MoreValuation Measures
Market Cap
6.52M
Enterprise Value
10.63M
Trailing P/E
4.30
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.84
Price/Book (mrq)
3.24
Enterprise Value/Revenue
2.15
Enterprise Value/EBITDA
4.06
Financial Highlights
Profitability and Income Statement
Profit Margin
-72.99%
Return on Assets (ttm)
2.26%
Return on Equity (ttm)
-56.37%
Revenue (ttm)
7.38M
Net Income Avi to Common (ttm)
-5.39M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
742.36k
Total Debt/Equity (mrq)
110.62%
Levered Free Cash Flow (ttm)
6.01M